These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 15999145)

  • 1. Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.
    Pehek EA; Nocjar C; Roth BL; Byrd TA; Mabrouk OS
    Neuropsychopharmacology; 2006 Feb; 31(2):265-77. PubMed ID: 15999145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of glutamate receptors in the ventral tegmental area is necessary for serotonin-2 receptor-induced increases in mesocortical dopamine release.
    Pehek EA; Hernan AE
    Neuroscience; 2015 Apr; 290():159-64. PubMed ID: 25637799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACP-103, a 5-HT2A/2C inverse agonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Li Z; Ichikawa J; Huang M; Prus AJ; Dai J; Meltzer HY
    Psychopharmacology (Berl); 2005 Dec; 183(2):144-53. PubMed ID: 16220333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity.
    Bortolozzi A; Díaz-Mataix L; Scorza MC; Celada P; Artigas F
    J Neurochem; 2005 Dec; 95(6):1597-607. PubMed ID: 16277612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptors in the prefrontal cortex regulate dopamine efflux to stress via descending glutamatergic feedback to the ventral tegmental area.
    Butts KA; Phillips AG
    Int J Neuropsychopharmacol; 2013 Sep; 16(8):1799-807. PubMed ID: 23590841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of 5-hydroxytryptamine (5-HT(2C) ) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex.
    Pozzi L; Acconcia S; Ceglia I; Invernizzi RW; Samanin R
    J Neurochem; 2002 Jul; 82(1):93-100. PubMed ID: 12091469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a differential medial prefrontal dopamine D1 and D2 receptor regulation of local and ventral tegmental glutamate and GABA release: a dual probe microdialysis study in the awake rat.
    Harte M; O'Connor WT
    Brain Res; 2004 Aug; 1017(1-2):120-9. PubMed ID: 15261107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2001 Jul; 907(1-2):151-5. PubMed ID: 11430898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of dopamine release by striatal 5-HT2C receptors.
    Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
    Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
    Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
    Pehek EA; McFarlane HG; Maguschak K; Price B; Pluto CP
    Brain Res; 2001 Jan; 888(1):51-59. PubMed ID: 11146051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced cortical serotonin 5-HT
    Mora S; Merchán A; Vilchez O; Aznar S; Klein AB; Ultved L; Campa L; Suñol C; Flores P; Moreno M
    Neuropharmacology; 2018 Dec; 143():10-19. PubMed ID: 30201211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
    Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
    J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade.
    Calcagno E; Carli M; Baviera M; Invernizzi RW
    J Neurochem; 2009 Jan; 108(2):521-32. PubMed ID: 19046357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium differs from anticonvulsant mood stabilizers in prefrontal cortical and accumbal dopamine release: role of 5-HT(1A) receptor agonism.
    Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2005 Jul; 1049(2):182-90. PubMed ID: 15936730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.
    Schmidt CJ; Fadayel GM
    Eur J Pharmacol; 1995 Feb; 273(3):273-9. PubMed ID: 7737334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Bonaccorso S; Meltzer HY; Li Z; Dai J; Alboszta AR; Ichikawa J
    Neuropsychopharmacology; 2002 Sep; 27(3):430-41. PubMed ID: 12225700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro.
    Arvanov VL; Wang RY
    Neuropsychopharmacology; 1998 Mar; 18(3):197-209. PubMed ID: 9471117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.